Hikma Pharmaceuticals sell Barclays PLC
Start price
06.01.26
/
50%
€18.40
Target price
06.01.27
-
Performance (%)
-12.42%
Price
08:45
?
Summary
This prediction is currently active. The price of Hikma Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.42%. Dividends of €0.41 are taken into consideration when calculating the performance. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hikma Pharmaceuticals | -0.403% | -0.403% |
| iShares Core DAX® | 3.023% | 2.202% |
| iShares Nasdaq 100 | 3.561% | 1.325% |
| iShares Nikkei 225® | 6.618% | 5.707% |
| iShares S&P 500 | 2.635% | 1.008% |
Comments by Barclays_PLC for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals (OTCMKTS:HKMPF) was downgraded by analysts at Barclays PLC to an "underweight" rating.
Ratings data for HKMPF provided by MarketBeat